T1	Participants 14 111	racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
T2	Participants 557 621	Subjects were recruited at 10 U.S. centers between 1993 and 2001
T3	Participants 623 693	One screening center had a major special recruitment effort for blacks
T4	Participants 698 765	another center had a major special recruitment effort for Hispanics
T5	Participants 788 906	155,000 subjects enrolled in PLCO, minority enrollment was as follows: black (5.0%), Hispanic (1.8%) and Asian (3.6%).
